Skip to main content

Table 2 Laboratory examination on admission of patients with C. psittaci pneumonia

From: Evaluation of clinical characteristics and risk factors associated with Chlamydia psittaci infection based on metagenomic next-generation sequencing

Characteristics

C. psittaci pneumonia (n = 46)

Non severe C. psittaci pneumonia (n = 29)

Severe C. psittaci pneumonia (n = 27)

P value

WBC (3.5–9.5 × 109 /L)

7.60(5.50, 9.88)

6.92(5.36, 9.24)

9.01(0.66,10.11)

0.0725

Neutrophils(1.8–6.3 × 109 /L)

6.61(4.35, 9.28)

6.25(4.25, 8.06)

8.06(5.66, 9.76)

0.035

Lymphocyte (1.1–3.2 × 109 /L)

0.65 ± 0.53

0.74 ± 0.51

0.48 ± 0.46

0.0016

CRP (0–8 mg/L)

184.61 ± 97.91

185.63 ± 95.55

201.55 ± 101.65

0.2531

ESR (0–20)

53.5(35.75, 72.5)

53.5(42, 68.5)

52(30, 72)

0.4727

PCT (0–0.5 ng/mL)

0.47(0.25, 2.42)

0.39(0.25, 1.87)

1.75(0.44, 4,32)

0.001

ALT (9–50 U/L)

50(25.5, 93.1)

54(27, 94.8)

54(31, 91.4)

0.4464

AST (15–40 U/L)

78.4(37.25, 133)

75(44, 121)

97(45, 168.5)

0.0786

LDH (120–250 U/L)

364.4(266.45,535.4)

327.2(216.63, 503.5)

449.35(296.08, 741)

0.0473

HBDH (72–182 U/L)

226.7(203.25, 438.2)

214.95(200.5, 438.2)

331.8(217, 592)

0.0388

CK (50–310 U/L)

172.9(83.45, 536)

174.45(90.475,485.93)

230.9(109.5, 1152.9)

0.0595

CK-MB(2–25U/L)

18.6(13.7, 34.4)

17.2(12.35, 25.23)

24(14.15, 49)

0.0441

IL-6 (0–11.09 pg/mL)

223.11 ± 406.95

106.69 ± 277.29

292.96 ± 395.44

0.1554

D-Dimer(0-0.55 mg/L)

2(0.61, 5.06)

1.46(0.59, 4.19)

2.83(0.94, 5.63)

0.0137

PT(9.8-12.1s)

12.9(11.98, 14.08)

12.9(12.2, 14)

12.9(12.3, 13.95)

0.4889

APTT(25.3-33.8s)

30.9(28.58, 34.85)

30.5(28.5, 33.3)

31(28.65, 37.9)

0.4752

FIB(1.8-3.5 g/L)

5.74(4.72, 6.38)

5.55(4.77, 6.17)

5.93(4.58, 6.51)

0.6472

TT(14-21s)

15.5(14.23, 16.63)

15.4(14.2, 16.7)

15.3(14.2, 16.3)

0.4481